Consistent with the high expression of the AURKA gene in germline-mutated cases, we found a statistically significant difference in the AURKA (i.e., proliferation) gene-expression signature between germline-mutated and non-mutated MBCs. The gene discussed is AURKA; the disease is maternal uniparental disomy of chromosome 20.